Object Scope of the procurement
Title: Rituximab or Biosimilar
Products/services: Pharmaceutical products📦
Short description:
“We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.”
Estimated value excluding VAT: EUR 1 💰
1️⃣
Additional products/services: Pharmaceutical products📦
Place of performance: Dublin🏙️
Main site or place of performance: CHI at Crumlin and Temple St.
Description of the procurement:
“We are seeking bids from suitably licensed organisations for the provision of Rituximab (originator or biosimilar) to Children’s Health Ireland.” Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
Scope of the procurement
Estimated total value excluding VAT: EUR 1 💰
Duration of the contract, framework agreement or dynamic purchasing system
The time frame below is expressed in number of months.
Description
Duration: 48
Duration of the contract, framework agreement or dynamic purchasing system
This contract is subject to renewal ✅ Description
Description of renewals:
“Tendered price to remain active for period of 24 months from date of issue. Successful candidates will be obliged to enter into a service level agreement...”
Description of renewals
Tendered price to remain active for period of 24 months from date of issue. Successful candidates will be obliged to enter into a service level agreement with the Hospital and sign the Hospitals standard SLA. The duration of the contract shall be for an initial 12- month period with an option to roll over for a further 3 periods of 12-month duration.
Show more Information about variants
Variants will be accepted ✅
Legal, economic, financial and technical information Economic and financial standing
Selection criteria as stated in the procurement documents
Technical and professional ability
Selection criteria as stated in the procurement documents
Procedure Type of procedure
Open procedure
Administrative information
Time limit for receipt of tenders or requests to participate: 2020-01-06
12:00 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️
Tender must be valid until: 2021-01-31 📅
Conditions for opening of tenders: 2020-01-06
12:00 📅
Complementary information Information about recurrence
This is a recurrent procurement ✅ Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
Review body
Name: Irish High Court
Postal town: Dublin
Country: Ireland 🇮🇪
Source: OJS 2019/S 231-565917 (2019-11-26)
Contract award notice (2020-03-09) Contracting authority Name and addresses
Postal town: Dublin 12
Object Scope of the procurement
Total value of the procurement (excluding VAT): EUR 175 000 💰
Award criteria
Quality criterion (name): Quality of supply
Quality criterion (weighting): 20 %
Quality criterion (name): Quality and fitness for purpose
Quality criterion (name): Value add
Quality criterion (weighting): 5 %
Price (weighting): 55 %
Procedure Administrative information
Previous publication concerning this procedure: 2019/S 231-565917
Award of contract
1️⃣
Title: Rituximab Biosimilar
Date of conclusion of the contract: 2020-02-26 📅
Information about tenders
Number of tenders received: 1
Name and address of the contractor
Name: Mundipharma
Postal address: Millbank House
Postal town: Dublin 18
Country: Ireland 🇮🇪
Region: Ireland🏙️
The contractor is an SME
Information on value of the contract/lot (excluding VAT)
Estimated total value of the contract/lot: EUR 260 000 💰
Currency code: EUR 💰
Lowest offer: 173000.00
Highest offer: 173000.00
Source: OJS 2020/S 050-118532 (2020-03-09)